Vaccine Production

NewsGuard 100/100 Score

Vaccines are produced in large scale as they need to be administered to large populations of children and adults to be effective as a public health tool. This large scale production is often a challenge.

Stages of vaccine production

Vaccine production has several stages. Process of vaccine manufacture has the following steps:

  • Inactivation – This involves making of the antigen preparation
  • Purification – The isolated antigen is purified
  • Formulation – The purified antigen is combined with adjuvants, stabilizers and preservatives to form the final vaccine preparation.

Generating the antigen from the microbe

The initial production involves generation of the antigen from the microbe. For this the virus or microbe is grown either on primary cells such as chicken eggs (e.g. in influenza) or on cell lines or cultured human cells (e.g. Hepatitis A). Bacteria against which the vaccines are developed may be grown in bioreactors (e.g. Haemophilus influenzae type b). The antigen may also be a toxin or toxoid from the organism (e.g. Diphtheria or tetanus) or it may be part of the microorganism as well. Proteins or parts from the organism can be generated in yeast, bacteria, or cell cultures. Bacteria or viruses may be weakened using chemicals or heat to make the vaccine (e.g. polio vaccine).

Isolation of the antigens

After the antigen is generated, it is isolated from the cells used to generate it. For weakened or attenuated viruses no further purification may be required. Recombinant proteins need many operations involving ultrafiltration and column chromatography for purification before they are ready for administration.

Adjuvants, stabilizers and preservatives

Once the antigen is developed the vaccine is formulated by adding adjuvants, stabilizers, and preservatives. The role of the adjuvant is to enhance the immune response of the antigen. The stabilizers increase the storage life, and preservatives allow the use of multi dose vials.
It is difficult to develop and produce combination vaccines due to the possibility of incompatibilities and interactions among the antigens and other ingredients of the vaccines.

Vaccine Production Requirements

The product needs to be protected from air, water and human contamination. The environment needs to be protected from spillage of the antigens

Further Reading

Last Updated: Jun 21, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, June 21). Vaccine Production. News-Medical. Retrieved on April 23, 2024 from

  • MLA

    Mandal, Ananya. "Vaccine Production". News-Medical. 23 April 2024. <>.

  • Chicago

    Mandal, Ananya. "Vaccine Production". News-Medical. (accessed April 23, 2024).

  • Harvard

    Mandal, Ananya. 2023. Vaccine Production. News-Medical, viewed 23 April 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers identify key barriers and outline recommendations for vaccine uptake in pregnant women